Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

Saved in:
Bibliographic Details
Title: Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.
Authors: Skinnerup Byskov C; Department of Oncology, Aarhus University Hospital, Denmark. cambys@rm.dk., Mortensen HR; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Biston MC; Centre Léon Bérard, Lyon, France., Broggi S; San Raffaele Hospital, Milan, Italy., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Crehange G; Curie Institute, Paris, France., Defraene G; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium., Doyen J; Centre Antoine Lacassagne, Nice, France., Ehmsen ML; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Fabiano S; University Hospital Zurich, Zurich, Switzerland., Fracchiola F; Department of medical physics, APSS, Trento, Italy., Goudjil F; Curie Institute, Paris, France., Haustermans K; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Jensen SE; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Jensen MF; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Lecornu M; Centre François Baclesse, Caen, France., Makocki S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Mana AL; Centre Antoine Lacassagne, Nice, France., Martignano A; Department of medical physics, APSS, Trento, Italy., Meijers A; Paul Scherrer Institute, Villigen, Switzerland., Mirandola A; National Centre of Oncology Adrotherapy, Pavia, Italy., Mitrea DA; Centre Antoine Lacassagne, Nice, France., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Møller DS; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Orlandi E; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Clinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy., Balermpas P; 1University Hospital Zurich, Zurich, Switzerland., Populaire P; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Scartoni D; Department of Proton Therapy, APSS, Trento., Serrand J; Centre Léon Bérard, Lyon, France., Shamshad M; EBG MedAustron GmbH, Austria., Slim N; San Raffaele Hospital, Milan, Italy., Vanoni V; Department of Radiation Oncology, APSS, Trento, Italy., Vela A; Centre François Baclesse, Caen, France., Vidal M; Centre Antoine Lacassagne, Nice, France., Vilches-Freixas G; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Weber D; Paul Scherrer Institute, Villigen, Switzerland., Hoffmann L; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.
Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2025 Mar 13; Vol. 64, pp. 406-414. Date of Electronic Publication: 2025 Mar 13.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Comparative Study; Multicenter Study
Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40079654
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Skinnerup+Byskov+C%22">Skinnerup Byskov C</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark. cambys@rm.dk.<br /><searchLink fieldCode="AU" term="%22Mortensen+HR%22">Mortensen HR</searchLink>; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Biston+MC%22">Biston MC</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Broggi+S%22">Broggi S</searchLink>; San Raffaele Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bütof+R%22">Bütof R</searchLink>; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Canters+R%22">Canters R</searchLink>; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Crehange+G%22">Crehange G</searchLink>; Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Defraene+G%22">Defraene G</searchLink>; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium.<br /><searchLink fieldCode="AU" term="%22Doyen+J%22">Doyen J</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Ehmsen+ML%22">Ehmsen ML</searchLink>; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Fabiano+S%22">Fabiano S</searchLink>; University Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fracchiola+F%22">Fracchiola F</searchLink>; Department of medical physics, APSS, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Goudjil+F%22">Goudjil F</searchLink>; Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Haustermans+K%22">Haustermans K</searchLink>; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium.<br /><searchLink fieldCode="AU" term="%22Jensen+SE%22">Jensen SE</searchLink>; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Jensen+MF%22">Jensen MF</searchLink>; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Lecornu+M%22">Lecornu M</searchLink>; Centre François Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Makocki+S%22">Makocki S</searchLink>; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Mana+AL%22">Mana AL</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Martignano+A%22">Martignano A</searchLink>; Department of medical physics, APSS, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Meijers+A%22">Meijers A</searchLink>; Paul Scherrer Institute, Villigen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mirandola+A%22">Mirandola A</searchLink>; National Centre of Oncology Adrotherapy, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Mitrea+DA%22">Mitrea DA</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Muijs+CT%22">Muijs CT</searchLink>; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Møller+DS%22">Møller DS</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.<br /><searchLink fieldCode="AU" term="%22Nordsmark+M%22">Nordsmark M</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Orlandi+E%22">Orlandi E</searchLink>; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Clinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Balermpas+P%22">Balermpas P</searchLink>; 1University Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Populaire+P%22">Populaire P</searchLink>; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium.<br /><searchLink fieldCode="AU" term="%22Scartoni+D%22">Scartoni D</searchLink>; Department of Proton Therapy, APSS, Trento.<br /><searchLink fieldCode="AU" term="%22Serrand+J%22">Serrand J</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Shamshad+M%22">Shamshad M</searchLink>; EBG MedAustron GmbH, Austria.<br /><searchLink fieldCode="AU" term="%22Slim+N%22">Slim N</searchLink>; San Raffaele Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Vanoni+V%22">Vanoni V</searchLink>; Department of Radiation Oncology, APSS, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Vela+A%22">Vela A</searchLink>; Centre François Baclesse, Caen, France.<br /><searchLink fieldCode="AU" term="%22Vidal+M%22">Vidal M</searchLink>; Centre Antoine Lacassagne, Nice, France.<br /><searchLink fieldCode="AU" term="%22Vilches-Freixas+G%22">Vilches-Freixas G</searchLink>; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Weber+D%22">Weber D</searchLink>; Paul Scherrer Institute, Villigen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hoffmann+L%22">Hoffmann L</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228709065%22">Acta oncologica (Stockholm, Sweden)</searchLink> [Acta Oncol] 2025 Mar 13; Vol. 64, pp. 406-414. <i>Date of Electronic Publication: </i>2025 Mar 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Comparative Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Medical+Journals+Sweden+AB%22">Medical Journals Sweden AB </searchLink><i>Country of Publication: </i>Sweden <i>NLM ID: </i>8709065 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1651-226X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220284186X%22">0284186X </searchLink><i>NLM ISO Abbreviation: </i>Acta Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40079654
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2340/1651-226X.2025.42774
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 406
    Titles:
      – TitleFull: Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Skinnerup Byskov C
      – PersonEntity:
          Name:
            NameFull: Mortensen HR
      – PersonEntity:
          Name:
            NameFull: Biston MC
      – PersonEntity:
          Name:
            NameFull: Broggi S
      – PersonEntity:
          Name:
            NameFull: Bütof R
      – PersonEntity:
          Name:
            NameFull: Canters R
      – PersonEntity:
          Name:
            NameFull: Crehange G
      – PersonEntity:
          Name:
            NameFull: Defraene G
      – PersonEntity:
          Name:
            NameFull: Doyen J
      – PersonEntity:
          Name:
            NameFull: Ehmsen ML
      – PersonEntity:
          Name:
            NameFull: Fabiano S
      – PersonEntity:
          Name:
            NameFull: Fracchiola F
      – PersonEntity:
          Name:
            NameFull: Goudjil F
      – PersonEntity:
          Name:
            NameFull: Haustermans K
      – PersonEntity:
          Name:
            NameFull: Jensen SE
      – PersonEntity:
          Name:
            NameFull: Jensen MF
      – PersonEntity:
          Name:
            NameFull: Lecornu M
      – PersonEntity:
          Name:
            NameFull: Makocki S
      – PersonEntity:
          Name:
            NameFull: Mana AL
      – PersonEntity:
          Name:
            NameFull: Martignano A
      – PersonEntity:
          Name:
            NameFull: Meijers A
      – PersonEntity:
          Name:
            NameFull: Mirandola A
      – PersonEntity:
          Name:
            NameFull: Mitrea DA
      – PersonEntity:
          Name:
            NameFull: Muijs CT
      – PersonEntity:
          Name:
            NameFull: Møller DS
      – PersonEntity:
          Name:
            NameFull: Nordsmark M
      – PersonEntity:
          Name:
            NameFull: Orlandi E
      – PersonEntity:
          Name:
            NameFull: Balermpas P
      – PersonEntity:
          Name:
            NameFull: Populaire P
      – PersonEntity:
          Name:
            NameFull: Scartoni D
      – PersonEntity:
          Name:
            NameFull: Serrand J
      – PersonEntity:
          Name:
            NameFull: Shamshad M
      – PersonEntity:
          Name:
            NameFull: Slim N
      – PersonEntity:
          Name:
            NameFull: Vanoni V
      – PersonEntity:
          Name:
            NameFull: Vela A
      – PersonEntity:
          Name:
            NameFull: Vidal M
      – PersonEntity:
          Name:
            NameFull: Vilches-Freixas G
      – PersonEntity:
          Name:
            NameFull: Weber D
      – PersonEntity:
          Name:
            NameFull: Hoffmann L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 03
              Text: 2025 Mar 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1651-226X
          Numbering:
            – Type: volume
              Value: 64
          Titles:
            – TitleFull: Acta oncologica (Stockholm, Sweden)
              Type: main
ResultId 1